Lotus Pharmaceutical Co., Ltd.
- Biotech or pharma, therapeutic R&D
Founded in 1966, Lotus (1795: TT) is international pharmaceutical company with global presence, focused on commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines. Lotus has a recognized best-in-class R&D and manufacturing platform in Asia and has established partnerships in nearly every global market including the U.S., Europe, Japan, China, and Brazil. Lotus runs over 100 pharmaceutical projects in development and registrations across Asia and the US, with over 250 commercial products.
The Company invests in diversified best portfolio consisting of high-barrier oncology, complex generics as well as 505(b)2 and NCE via internal R&D investment and licensing-in partnership, and also strengthens its portfolio by adding biosimilar products with support from strategic partners. Its industry-leading infrastructure certified by advanced regulatory authorities, including US FDA, EU EMA, Japan PMDA, China FDA, and Brazil ANVISA.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}